Aldicarb poisoning: A case report with prolonged cholinesterase inhibition and improvement after pralidoxime therapy

J. L. Burgess, J. N. Bernstein, K. Hurlbut

Research output: Contribution to journalArticlepeer-review

33 Scopus citations

Abstract

Aldicarb is the most potent of the commercially available carbamate pesticides and is an unusual source of acute human poisonings. We present the case of a 43-year-old man exposed to aldicarb who developed severe cholinergic symptoms and progressive weakness requiring intubation for 5 days. Both his red blood cell cholinesterase and plasma pseudocholinesterase levels were depressed for a minimum of 44 hours. He demonstrated neuromuscular improvement concurrent with pralidoxime administration. The pertinent medical literature on aldicarb poisoning is reviewed.

Original languageEnglish (US)
Pages (from-to)221-224
Number of pages4
JournalArchives of internal medicine
Volume154
Issue number2
DOIs
StatePublished - Jan 31 1994

ASJC Scopus subject areas

  • Internal Medicine

Fingerprint Dive into the research topics of 'Aldicarb poisoning: A case report with prolonged cholinesterase inhibition and improvement after pralidoxime therapy'. Together they form a unique fingerprint.

Cite this